{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T14:36:37Z","timestamp":1776954997302,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"DOI":"10.1007\/s00115-026-01972-5","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T13:39:14Z","timestamp":1776951554000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Psychische Erkrankungen und Fahreignung\u00a0\u2013 ein Update","Mental diseases and driving ability\u2014An update"],"prefix":"10.1007","author":[{"given":"Alexander","family":"Brunnauer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Zwanzger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerd","family":"Laux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,23]]},"reference":[{"key":"1972_CR1","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.biopsych.2015.12.002","volume":"79","author":"SJ Broyd","year":"2016","unstructured":"Broyd\u00a0SJ, van Hell\u00a0HH, Beale\u00a0C et\u00a0al (2016) Acute and Chronic Effects of Cannabinoids on Human Cognition\u2011A Systematic Review. Biol Psychiatry 79:557\u2013567","journal-title":"Biol Psychiatry"},{"key":"1972_CR2","unstructured":"In: Brunnauer\u00a0A, Graw\u00a0M, Laux\u00a0G (eds) Fahreignung bei psychischen Erkrankungen, 2\u00a0edn. Medizinisch Wissenschaftliche Verlagsgesellschaft, Berlin, pp\u00a01\u20137"},{"key":"1972_CR3","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1093\/ijnp\/pyab031","volume":"24","author":"A Brunnauer","year":"2021","unstructured":"Brunnauer\u00a0A, Herpich\u00a0F, Zwanzger\u00a0P et\u00a0al (2021b) Driving Performance Under Treatment of Most Frequently Prescribed Drugs for Mental Disorders: A Systematic Review of Patient Studies. Int J Neuropsychopharmacol 24:679\u2013693","journal-title":"Int J Neuropsychopharmacol"},{"key":"1972_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-56015-1_267-271","volume-title":"NeuroPsychopharmacotherapy","author":"A Brunnauer","year":"2021","unstructured":"Brunnauer\u00a0A, Laux\u00a0G (2021a) Effects of psychopharmacological medicines upon driving ability. In: Riederer\u00a0P, Laux\u00a0G, Nagatsu\u00a0T, Le\u00a0W, Riederer\u00a0C (eds) NeuroPsychopharmacotherapy. Springer, Cham https:\/\/doi.org\/10.1007\/978-3-319-56015-1_267-271"},{"key":"1972_CR5","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00115-014-4075-x","volume":"85","author":"A Brunnauer","year":"2014","unstructured":"Brunnauer\u00a0A, Widder\u00a0B, Laux\u00a0G (2014) Grundlagen der Fahrtauglichkeitsbeurteilung bei neurologischen und psychischen Erkrankungen. Nervenarzt 85:805\u2013810","journal-title":"Nervenarzt"},{"key":"1972_CR6","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s13181-020-00819-y","volume":"17","author":"KT Cameron-Burr","year":"2021","unstructured":"Cameron-Burr\u00a0KT, Conicella\u00a0A, Neavyn\u00a0MJ (2021) Opioid use and driving performance. J\u00a0Med Toxicol 17:289\u2013308","journal-title":"J Med Toxicol"},{"key":"1972_CR7","unstructured":"Bundesanstalt f\u00fcr Stra\u00dfenwesen (2020) Geeignete Testverfahren und -ger\u00e4te im Rahmen der Fahreignungsbegutachtung oder einer Eignungsuntersuchung nach \u00a7\u00a011 Absatz\u00a09 der Fahrerlaubnis-Verordnung (FeV) (Stand 19.\u00a0Oktober 2020). https:\/\/www.bast.de\/BASt_2017\/DE\/Verkehrssicherheit\/Qualitaetsbewertung\/Anerkennung\/u3-anerkennung\/geeignete-Verfahren.html. Accessed 3.4.2021"},{"key":"1972_CR8","unstructured":"Charlton JL, Di Stefano M, Dow J et\u00a0al (2020) Influence of chronic illness on crash involvement of motor vehicle drivers: 3rd edition, Melbourne, Australia: Monash University Accident research Centre. https:\/\/www.monash.edu\/__data\/assets\/pdf_file\/0008\/2955617\/Chronic-illness-and-MVC-risk_Report-MUARC-report-no-353_JUNE2022.pdf. Accessed 29.5.2025"},{"key":"1972_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1159\/000478740","volume":"44","author":"MH Connors","year":"2017","unstructured":"Connors\u00a0MH, Ames\u00a0D, Woodward\u00a0M et\u00a0al (2017) Mild Cognitive Impairment and Driving Cessation: A 3\u2011Year Longitudinal Study. Dement Geriatr Cogn Disord 44:63\u201370","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1972_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/arclin\/acy106","volume":"35","author":"SF Crowe","year":"2020","unstructured":"Crowe\u00a0SF, Cammisuli\u00a0DM, Stranks\u00a0EK (2020) Widespread Cognitive Deficits in Alcoholism Persistent Following Prolonged Abstinence: An Updated Meta-analysis of Studies That Used Standardised Neuropsychological Assessment Tools. Arch Clin Neuropsychol 35:31\u201345","journal-title":"Arch Clin Neuropsychol"},{"key":"1972_CR11","first-page":"143","volume-title":"Fahreignung bei psychischen Erkrankungen","author":"V Dittman","year":"2025","unstructured":"Dittman\u00a0V (2025) Aufmerksamkeitsdefizit und Hyperaktivit\u00e4tsst\u00f6rung (ADHS) im Erwachsenenalter. In: Brunnauer\u00a0A, Graw\u00a0M, Laux\u00a0G (eds) Fahreignung bei psychischen Erkrankungen, 2\u00a0edn. Medizinisch Wissenschaftliche Verlagsgesellschaft, Berlin, pp\u00a0143\u2013149","edition":"2"},{"key":"1972_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/psyg.12115","volume":"16","author":"R Fujito","year":"2016","unstructured":"Fujito\u00a0R, Kamimura\u00a0N, Ikeda\u00a0M et\u00a0al (2016) Comparing the driving behaviours of individuals with frontotemporal lobar degeneration and those with Alzheimer\u2019s disease. Psychogeriatrics 16:27\u201333","journal-title":"Psychogeriatrics"},{"key":"1972_CR13","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1080\/15389588.2023.2174801","volume":"24","author":"H Gjerde","year":"2023","unstructured":"Gjerde\u00a0H, Frost\u00a0J (2023) Prevalence of alcohol and drugs among drivers killed in road traffic crashes in Norway during 2011\u20132020. Traffic Inj Prev 24:256\u2013261","journal-title":"Traffic Inj Prev"},{"key":"1972_CR14","unstructured":"G\u00f3mez-Taleg\u00f3n T, Fierro I, Del R\u00edo MC et\u00a0al (2011) Classification of medicinal drugs and driving: Co-ordination and synthesis report. DRUID 6th framework programme. Deliverable D 4.4.1. https:\/\/www.bast.de\/Druid\/EN\/deliverales-list\/downloads\/Deliverable_4_4_1.html?nn=613800. Accessed 6.6.2025"},{"key":"1972_CR15","unstructured":"Gr\u00e4cmann N, Albrecht M (2022) Begutachtungsleitlinien zur Kraftfahreignung, Bundesanstalt f\u00fcr Stra\u00dfenwesen, Bergisch Gladbach, Stand 01.\u00a0Juni 2022. https:\/\/bast.opus.hbz-nrw.de\/opus45-bast\/frontdoor\/deliver\/index\/docId\/2664\/file\/Begutachtungsleitlinien+2022.pdf. Accessed 29.5.2025"},{"key":"1972_CR16","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1093\/jat\/bkae024","volume":"48","author":"G Heide","year":"2024","unstructured":"Heide\u00a0G, Jamt\u00a0REG, Fainberg-Sandbu\u00a0J et\u00a0al (2024) Driving under the influence of cocaine and MDMA: Relationship between blood concentrations and results from clinical test of impairment. J\u00a0Anal Toxicol 48:380\u2013387","journal-title":"J Anal Toxicol"},{"key":"1972_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s40621-017-0107-x","volume":"4","author":"LL Hill","year":"2017","unstructured":"Hill\u00a0LL, Lauzon\u00a0VL, Winbrock\u00a0EL et\u00a0al (2017) Depression, antidepressants and driving safety. Inj Epidemiol 4:10","journal-title":"Inj Epidemiol"},{"key":"1972_CR18","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1080\/15389588.2023.2204984","volume":"24","author":"AK H\u00f8ye","year":"2023","unstructured":"H\u00f8ye\u00a0AK, Storesund-Hesjevoll\u00a0I (2023) Alcohol and driving\u2014How bad is the combination? A meta-analysis. Traffic Inj Prev 24:373\u2013378","journal-title":"Traffic Inj Prev"},{"key":"1972_CR19","doi-asserted-by":"publisher","first-page":"132","DOI":"10.52778\/ppt20250009","volume":"32","author":"G Laux","year":"2025","unstructured":"Laux\u00a0G, Brunnauer\u00a0A (2025) Fahreignung unter Psychopharmaka \u2013 ein Update. Psychopharmakotherapie 32:132\u2013143","journal-title":"Psychopharmakotherapie"},{"key":"1972_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.aap.2023.107367","volume":"195","author":"B McManus","year":"2024","unstructured":"McManus\u00a0B, Kana\u00a0R, Rajpari\u00a0I et\u00a0al (2024) Risky driving behavior among individuals with autism, ADHD, and typically developing persons. Accid Anal Prev 195:107367","journal-title":"Accid Anal Prev"},{"key":"1972_CR21","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41583-021-00466-4","volume":"22","author":"JG Ramaekers","year":"2021","unstructured":"Ramaekers\u00a0JG, Mason\u00a0NL, Kloft\u00a0L et\u00a0al (2021) The why behind the high: determinants of neurocognition during acute cannabis exposure. Nat Rev Neurosci 22:439\u2013454","journal-title":"Nat Rev Neurosci"},{"key":"1972_CR22","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1177\/07067437221128468","volume":"68","author":"MJ Rapoport","year":"2023","unstructured":"Rapoport\u00a0MJ, Chee\u00a0JN, Prabha\u00a0T et\u00a0al (2023) A systematic review of the risks of motor vehicle crashes associated with psychiatric disorders. Can J Psychiatry 68:221\u2013224","journal-title":"Can J Psychiatry"},{"key":"1972_CR23","first-page":"110","volume-title":"Fahreignung bei psychischen Erkrankungen","author":"M Rentrop","year":"2025","unstructured":"Rentrop\u00a0M, Cimpianu\u00a0C (2025a) Angst- oder furchtbezogene St\u00f6rungen, Zwangsst\u00f6rung oder verwandte St\u00f6rungen, spezifisch Belastungs-assoziierte und Dissoziative St\u00f6rungen. In: Brunnauer\u00a0A, Graw\u00a0M, Laux\u00a0G (eds) Fahreignung bei psychischen Erkrankungen, 2\u00a0edn. Medizinisch Wissenschaftliche Verlagsgesellschaft, Berlin, pp\u00a0110\u2013117","edition":"2"},{"key":"1972_CR24","first-page":"118","volume-title":"Fahreignung bei psychischen Erkrankungen","author":"M Rentrop","year":"2025","unstructured":"Rentrop\u00a0M, Cimpianu\u00a0C (2025b) Pers\u00f6nlichkeitsst\u00f6rungen und zugeh\u00f6rige Pers\u00f6nlichkeitsmerkmale. In: Brunnauer\u00a0A, Graw\u00a0M, Laux\u00a0G (eds) Fahreignung bei psychischen Erkrankungen, 2\u00a0edn. Medizinisch Wissenschaftliche Verlagsgesellschaft, Berlin, pp\u00a0118\u2013126","edition":"2"},{"key":"1972_CR25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.psychres.2005.07.004","volume":"137","author":"AC Ruocco","year":"2005","unstructured":"Ruocco\u00a0AC (2005) The neuropsychology of borderline personality disorder: a\u00a0meta-analysis and review. Psychiatry Res 137:191\u2013202","journal-title":"Psychiatry Res"},{"key":"1972_CR26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.drugalcdep.2018.08.041","volume":"194","author":"S Sabrini","year":"2019","unstructured":"Sabrini\u00a0S, Wang\u00a0GY, Lin\u00a0JC, Ian\u00a0IK et\u00a0al (2019) Methamphetamine use and cognitive function: A systematic review of neuroimaging research. Drug Alcohol Depend 194:75\u201387","journal-title":"Drug Alcohol Depend"},{"key":"1972_CR27","unstructured":"Statistisches Bundesamt (Destatis) (2022) Verkehrsunf\u00e4lle. Unf\u00e4lle unter dem Einflu\u00df von Alkohol oder anderen berauschenden Mitteln im Stra\u00dfenverkehr \u2013 20132021. https:\/\/www.destatis.de\/DE\/Themen\/Gesellschaft-Umwelt\/Verkehrsunfaelle\/Publikationen\/Downloads-Verkehrsunfaelle\/unfaelle-alkohol-5462404217004-1_2021449.pdf?__blob=publicationFile. Accessed 6.6.2025"},{"key":"1972_CR28","first-page":"7","volume":"47","author":"M Soyka","year":"2014","unstructured":"Soyka\u00a0M (2014) Opioids and traffic safety - focus on buprenorphine. Pharmacopsychiatry 47:7\u201317","journal-title":"Pharmacopsychiatry"},{"key":"1972_CR29","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1080\/15389588.2012.689451","volume":"14","author":"MC Strand","year":"2013","unstructured":"Strand\u00a0MC, Fjeld\u00a0B, Arnestad\u00a0M et\u00a0al (2013) Can patients receiving opioid maintenance therapy safely drive? A systematic review of epidemiological and experimental studies on driving ability with a focus on concomitant methadone or buprenorphine administration. Traffic Inj Prev 14:26\u201338","journal-title":"Traffic Inj Prev"},{"key":"1972_CR30","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1111\/jgs.16077","volume":"67","author":"M Toepper","year":"2019","unstructured":"Toepper\u00a0M, Falkenstein\u00a0M (2019) Driving Fitness in Different Forms of Dementia: An Update. J\u00a0Am Geriatr Soc 67:2186\u20132192","journal-title":"J Am Geriatr Soc"},{"key":"1972_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-017-1481-1","volume":"17","author":"CA Unsworth","year":"2017","unstructured":"Unsworth\u00a0CA, Baker\u00a0AM, So\u00a0MH et\u00a0al (2017) A systematic review of evidence for fitness-to-drive among people with the mental health conditions of schizophrenia, stress\/anxiety disorder, depression, personality disorder and obsessive-compulsive disorder. BMC Psychiatry 17:318","journal-title":"BMC Psychiatry"},{"key":"1972_CR32","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.pain.2005.12.019","volume":"122","author":"DS Veldhuijzen","year":"2006","unstructured":"Veldhuijzen\u00a0DS, van Wijck\u00a0AJM, Wille\u00a0F et\u00a0al (2006) Effect of chronic nonmalignant pain on highway driving performance. Pain 122:28\u201335","journal-title":"Pain"},{"key":"1972_CR33","first-page":"135","volume-title":"Fahreignung bei psychischen Erkrankungen","author":"L Zellner","year":"2025","unstructured":"Zellner\u00a0L, Richter-Schmidinger\u00a0T (2025) Autismus-Spektrum-St\u00f6rung. In: Brunnauer\u00a0A, Graw\u00a0M, Laux\u00a0G (eds) Fahreignung bei psychischen Erkrankungen, 2\u00a0edn. Medizinisch Wissenschaftliche Verlagsgesellschaft, Berlin, pp\u00a0135\u2013142","edition":"2"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-026-01972-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00115-026-01972-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-026-01972-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T13:39:20Z","timestamp":1776951560000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00115-026-01972-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,23]]},"references-count":33,"alternative-id":["1972"],"URL":"https:\/\/doi.org\/10.1007\/s00115-026-01972-5","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,23]]},"assertion":[{"value":"21 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"A.\u00a0Brunnauer erhielt Forschungsf\u00f6rderung und Honorare f\u00fcr Vortragst\u00e4tigkeiten von Fa. Schuhfried GmbH, Recordati Pharma GmbH, der Bayerischen Landes\u00e4rztekammer und der Berliner \u00c4rztekammer. Vorstandschaft und Mitgliedschaften in AGNP, DGVM, GNP und im Expertenausschuss der Bundesanstalt f\u00fcr Stra\u00dfenwesen (BASt). P.\u00a0Zwanzger erhielt Honorare f\u00fcr Vortragst\u00e4tigkeiten oder die Teilnahme an Advisory-Board-Meetings von Janssen Cilag\/Johnson & Johnson, Schwabe, Sympatient, GAJA, MagVenture, Boehringer, Idorsia und Neuraxpharm. P.\u00a0Zwanzger ist Vorstandsmitglied der Deutschen Gesellschaft f\u00fcr Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde, Leiter des DGPPN-Referats Digitale Psychiatrie und Psychotherapie sowie Erster Vorsitzender der Gesellschaft f\u00fcr Angstforschung (GAF e.\u202fV.). G.\u00a0Laux gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}